Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth
Open Access
- 29 May 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 37 (14), 4559-4569
- https://doi.org/10.1093/nar/gkp451
Abstract
The development of short interfering RNA (siRNA), has provided great hope for therapeutic targeting of specific genes responsible for patholological disorders. However, the poor cellular uptake and bioavailability of siRNA remain a major obstacle to their clinical development and most strategies that propose to improve siRNA delivery remain limited for in vivo applications. In this study, we report a novel peptide-based approach, MPG-8 an improved variant of the amphipathic peptide carrier MPG, that forms nanoparticles with siRNA and promotes their efficient delivery into primary cell lines and in vivo upon intra-tumoral injection. Moreover, we show that functionalization of this carrier with cholesterol significantly improves tissue distribution and stability of siRNA in vivo, thereby enhancing the efficiency of this technology for systemic administration following intravenous injection without triggering any non-specific inflammatory response. We have validated the therapeutic potential of this strategy for cancer treatment by targeting cyclin B1 in mouse tumour models, and demonstrate that tumour growth is compromised. The robustness of the biological response achieved through this approach, infers that MPG 8-based technology holds a strong promise for therapeutic administration of siRNA.Keywords
This publication has 38 references indexed in Scilit:
- A New Potent Secondary Amphipathic Cell–penetrating Peptide for siRNA Delivery Into Mammalian CellsMolecular Therapy, 2009
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized MiceCell, 2008
- Nonviral delivery of synthetic siRNAs in vivoJCI Insight, 2007
- Lung Delivery Studies Using siRNA Conjugated to TAT(48−60) and Penetratin Reveal Peptide Induced Reduction in Gene Expression and Induction of Innate ImmunityBioconjugate Chemistry, 2007
- In vivo optical imaging of integrin αV-β3 in mice using multivalent or monovalent cRGD targeting vectorsMolecular Cancer, 2007
- A non-covalent peptide-based carrier for in vivo delivery of DNA mimicsNucleic Acids Research, 2007
- Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effectNucleic Acids Research, 2006
- Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivoOncogene, 2005
- Cell-penetrating peptides: tools for intracellular delivery of therapeuticsCellular and Molecular Life Sciences, 2005
- siRNAs: applications in functional genomics and potential as therapeuticsNature Reviews Drug Discovery, 2004